3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
45
Breast Neoplasms
20
Myelodysplastic Syndromes
19
Prostatic Neoplasms
12
Neoplasms
12
Leukemia, Myelomonocytic, Chronic
12
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Recurrence
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Lung Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Melanoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Biphenotypic, Acute
4
Cholangiocarcinoma
4
Thrombocythemia, Essential
3
Interventions
Etanercept
12
Adalimumab
12
Infliximab
7
golimumab
4
Tumor Necrosis Factor Inhibitors
4
Certolizumab Pegol
4
Abatacept
4
tofacitinib
2
tocilizumab
2
Rituximab
2
Antirheumatic Agents
2
Vitamin D
1
Vaccines
1
Syringes
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Radioimmunodetection
1
Prednisone
1
Practice Guidelines as Topic
1
Phlebotomy
1
Observation
1
Nivolumab
1
Methotrexate
1
Methods
1
Lysine Acetyltransferase 5
1
Licensure
1
Leflunomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthritis, Rheumatoid
×
Injections
×
Clear all
NCT05090124
2025-01-14
REALISE
NHS Greater Glasgow and Clyde
Phase NA
Completed
46 enrolled